Two collagen receptors team up to drive bone regeneration

A study in the International Journal of Oral Science finds that β1 integrin and DDR2 work together to steer skeletal progenitor cells during cranial bone repair. The results point to a cooperative collagen-sensing pathway that could inform future therapies for difficult bone-healing cases.

Why it matters: - Bone healing depends on skeletal progenitor cells reaching an injury site, multiplying and turning into bone-forming cells. - The study identifies a two-receptor collagen-sensing system that helps control that process. - The findings could support new strategies to improve cranial bone regeneration in injury-related or degenerative skeletal disorders.

What happened: - Researchers published the study online Aug. 18, 2026, in the International Journal of Oral Science. - The team examined how β1 integrin and DDR2 function in GLI1+ skeletal progenitor cells during cranial bone regeneration. - The researchers used conditional knockout mice, deleting Itgb1, Ddr2 or both genes in GLI1+ skeletal progenitor cells. - The team created a critical-sized skull defect, treated it with BMP2 and tracked repair over four weeks.

The details: - In control mice, new bone formed extensively at the injury site and healing was nearly complete. - Deleting Itgb1 alone reduced bone volume by 47%. - Deleting Ddr2 alone reduced bone volume by 36%. - Deleting both receptors reduced bone volume by 73% and left only a small amount of new bone. - In control mice, GLI1+ cells migrated from cranial sutures into the defect and contributed to new bone. - Loss of either receptor reduced GLI1+ cell migration and proliferation. - Removing both receptors produced the strongest drop in migration and proliferation. - Loss of either receptor also impaired differentiation into chondrocytes, preosteoblasts and mature osteoblasts. - Cell-culture experiments showed reduced cell spreading, disrupted actin cytoskeleton structure and fewer focal adhesions after loss of either receptor. - Cells lacking DDR2 showed less active β1 integrin, suggesting DDR2 helps activate β1 integrin during collagen interactions. - Loss of either receptor also reduced nuclear YAP1 localization, with the strongest effect when both receptors were absent. - Heterozygous experiments showed little effect when one copy of either gene was inactivated alone. - Inactivating one copy of both genes at the same time significantly impaired skeletal progenitor cell function. - The paper’s DOI is the study DOI. - The journal’s website is the journal site. - The work was supported by NIH/NIDCR grant DE029465, Department of Defense Grant CDMRP W81XWH-20-1-0571, funds from the University of Michigan School of Dentistry Department of Periodontics and Oral Medicine, and the Michigan Musculoskeletal Health Core Center through NIH/NIAMS P30 AR069620.

Between the lines: - The results show that β1 integrin and DDR2 do not act as isolated receptors in this setting. - The strongest defects appeared when both receptors were removed, which points to cooperation rather than redundancy alone. - DDR2’s link to β1 integrin activation suggests the receptors may work in a linked signaling pathway tied to the collagen-rich bone environment. - The study’s genetic interaction data strengthens the case that the two receptors jointly shape skeletal progenitor cell behavior.

What's next: - The researchers suggest that targeting both receptors could be more effective than focusing on one receptor alone. - Future work will likely test whether this collagen-sensing pathway can be translated into therapies that improve cranial bone repair in patients.

The bottom line: - Bone regeneration appears to rely on a cooperative partnership between β1 integrin and DDR2, not either receptor by itself.